BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


Medarex, Inc. 

707 State Road

Princeton  New Jersey  08540  U.S.A.
Phone: 609-430-2880 Fax: 609-430-2850


View Clinical Trials from BioPharm Insight


Kirin Brewery Co., Ltd.  Exclusive distributor of TC Mouse containing all of the human antibody genes.

Athersys  A collaboration to develop novel therapeutics produced through the joint application of Medarex's HuMAb Mouse® technology and Athersys' RAGE technology. The companies plan to jointly discover, develop and commercialize fully human antibodies as therapeutics.

Eos Biotechnology, Inc.  Applied genomics partnership to develop human antibodies against disease targets.

Johnson & Johnson  Broad HuMAb-Mouse antibody development agreement.

LeukoSite (Acquired by Millennium Pharmaceuticals)  Broad HuMAb-Mouse antibody development agreement.

Novartis Corporation  Broad HuMAb-Mouse antibody development agreement.

IDM S.A.  Broad HuMAb-Mouse antibody development agreement and Anti-CTLA-4 cancer vaccine development.

Biosite Incorporated  Trans-Phage Technology, high-throughput human antibody development for genomic target validation.

Ambit Biosciences  Co-development of Antibody therapeutics for targets discovered by Ambit

Raven Biotechnologies, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.

ImmunoGen  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.

Eli Lilly 

Bristol-Myers Squibb 



 Company News
Medarex, Inc. (MEDX) Announces Expiration of Offer to Repurchase its 2.25% Convertible Senior Notes Due May 15, 2011 10/26/2009 9:03:25 AM
Medarex, Inc. (MEDX) Issues Notice of Change in Control to Holders of its Convertible Notes 9/24/2009 1:40:34 PM
Bristol-Myers Squibb Company (BMY) (JOBS) Still Hungry for Deals After Medarex, Inc. (MEDX) (JOBS) 9/24/2009 7:19:46 AM
Bristol-Myers Squibb Company (BMY) Completes Tender Offer for Medarex, Inc. (MEDX) 9/1/2009 10:24:20 AM
Bristol-Myers Squibb Company (BMY) (JOBS) Extends Tender Offer for Medarex, Inc. (MEDX) (JOBS) 8/21/2009 6:47:17 AM
Bristol-Myers Squibb Company (BMY) Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Medarex, Inc. (MEDX) 8/12/2009 8:28:58 AM
Medarex, Inc. (MEDX) Announces 2009 Second Quarter Financial Results 7/31/2009 9:31:12 AM
Bristol-Myers Squibb Company (BMY) Begins Tender Offer to Acquire Medarex, Inc. (MEDX) 7/28/2009 10:01:53 AM
Bristol-Myers Squibb Company (BMY) (JOBS) Agrees to Buy Medarex, Inc. (MEDX) (JOBS) for $2.4 Billion 7/22/2009 6:12:52 PM
Medarex, Inc. (MEDX) to Receive Milestone Payment from FibroGen, Inc. for the Initiation of a Phase 2 Study of FG-3019 in Patients with Diabetic Kidney Disease 7/13/2009 9:06:27 AM